1
FOR IMMEDIATE RELEASE December 8, 2014 AUSTIN, TX, USA December 8, 2014– International Biomedical, a medical device company specializing in neonatal products, announces its partnership with SenTec, a medical device company that develops, manufactures and markets transcutaneous digital monitoring systems. International Biomedical will serve as the distributor of the SenTec transcutaneous digital monitoring system in the Middle East. The SenTec is compatible with International Biomedical's Airborne infant transport incubators that are equipped with TXP high frequency ventilators. The SenTec can be mounted to any of the Airborne transport incubator systems or can stand alone. The SenTec provides noninvasive, real time monitoring of ventilation and oxygenation. ABOUT SENTEC Founded in 1999, SenTec AG is a medical device company that develops, manufactures and markets technologies and products for noninvasive patient monitoring. SenTec AG gained attention and worldwide appreciation due to its digital, combined tcPCO2/SpO2 sensors enabling noninvasive and continuous ventilation and oxygenation monitoring. SenTec AG meanwhile has become a prominent player in this field with its products and solutions being used in healthcare environments worldwide. ABOUT INTERNATIONAL BIOMEDICAL International Biomedical is an Austin, Texas based company that provides neonatal transport incubators, infant resuscitators, nitric oxide delivery systems, and blood chemistry systems to hospitals worldwide. Our passion is to provide innovative products and technologies that will result in the best outcomes for the newborn infant, the critically ill and their families. ### If you would like more information about this topic, please contact Greg Will at (512) 873 0033 or email at [email protected]. Contact Greg Will Telephone (512) 873 0033 Email [email protected] Website www.intbio.com INTERNATIONAL BIOMEDICAL TO SERVE AS SENTEC DISTRIBUTOR IN THE MIDDLE EAST

FORIMMEDIATERELEASE! December!8,!2014! - INT-BIOint-bio.com/wp-content/uploads/2016/06/international... · 2016-08-27 · FORIMMEDIATERELEASE! December!8,!2014!!!!! AUSTIN,!TX,USA!December!8,!2014–!InternationalBiomedical,amedicaldevicecompanyspecializingin!

Embed Size (px)

Citation preview

 

  FOR  IMMEDIATE  RELEASE  December  8,  2014  

 

 

 

 

 

AUSTIN,  TX,  USA  December  8,  2014–  International  Biomedical,  a  medical  device  company  specializing  in  neonatal  products,  announces  its  partnership  with  SenTec,  a  medical  device  company  that  develops,  manufactures  and  markets  transcutaneous  digital  monitoring  systems.  

International  Biomedical  will  serve  as  the  distributor  of  the  SenTec  transcutaneous  digital  monitoring  

system  in  the  Middle  East.    The  SenTec  is  compatible  with  International  Biomedical's  Airborne  infant  transport  incubators  that  are  equipped  with  TXP  high  frequency  ventilators.    The  SenTec  can  be  mounted  to  any  of  the  Airborne  transport  incubator  systems  or  can  stand  alone.    The  SenTec  provides  

noninvasive,  real  time  monitoring  of  ventilation  and  oxygenation.  

ABOUT  SENTEC  

Founded  in  1999,  SenTec  AG  is  a  medical  device  company  that  develops,  manufactures  and  markets  technologies  and  products  for  noninvasive  patient  monitoring.  SenTec  AG  gained  attention  and  

worldwide  appreciation  due  to  its  digital,  combined  tcPCO2/SpO2  sensors  enabling  noninvasive  and  continuous  ventilation  and  oxygenation  monitoring.  SenTec  AG  meanwhile  has  become  a  prominent  player  in  this  field  with  its  products  and  solutions  being  used  in  healthcare  environments  worldwide.  

ABOUT  INTERNATIONAL  BIOMEDICAL  

International  Biomedical  is  an  Austin,  Texas  based  company  that  provides  neonatal  transport  incubators,  

infant  resuscitators,  nitric  oxide  delivery  systems,  and  blood  chemistry  systems  to  hospitals  worldwide.    Our  passion  is  to  provide  innovative  products  and  technologies  that  will  result  in  the  best  outcomes  for  the  newborn  infant,  the  critically  ill  and  their  families.      

#  #  #  

If  you  would  like  more  information  about  this  topic,  please  contact  Greg  Will  at  (512)  873  -­‐  0033  or  

email  at  gwill@int-­‐bio.com.  

Contact   Greg  Will  Telephone   (512)  873  -­‐  0033  

Email   gwill@int-­‐bio.com  Website   www.int-­‐bio.com  

INTERNATIONAL  BIOMEDICAL  TO  SERVE  AS  SENTEC  DISTRIBUTOR  IN  THE  MIDDLE  EAST